Press Releases

SAN DIEGO, Nov. 11 /PRNewswire/ -- Nirvanix, the premier enterprise cloud storage service provider, has been selected as a winner of the Tech Awards Circle, taking Gold in the Enterprise Service category for Nirvanix CloudNAS. Winners were selected by an independent circle of publication reviewers/journalists from nominations based on a broad range of achievements -- from product and technology innovations to talented executive leadership and engineering innovators.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090113/LA58239LOGO)

Tech Awards Circle celebrates the products, services, vendors and individuals making a difference in the industry today. The winners represent a broad range of achievements, from hardware to software to services in consumer/SOHO, SMB, midrange, and enterprise markets. Gold, silver and bronze awards were given out in each category.

"Despite overwhelmingly strong competition, Nirvanix exhibited true industry excellence to be recognized among the top of the Tech Awards Circle," said Kevin Anderson, awards program coordinator. "Our judges were pleased at the level of submissions from all the vendors entering this year's competition, so to be named a winner of this prestigious award is a testament to the quality and innovation unrivaled in the high tech community. We wish them continued success and look forward to them defending their title during the next awards period."

"We are honored that this independent group of journalists has recognized CloudNAS as a best of breed offering in the Enterprise Services category," said Jim Zierick, President and CEO of Nirvanix. "We have worked hard to ensure that our technology enables organizations to solve their most pressing storage challenges while increasing operational efficiency and reducing costs. Winning an independent review such as Tech Awards Circle validates our progress."

Nirvanix CloudNAS is a fast, secure and easy way to gain access to the benefits of cloud storage. As the world's first software-only NAS solution accessible via CIFS or NFS, CloudNAS offers enhanced secure data transfers to any of Nirvanix's globally distributed storage nodes using integrated AES 256-bit encryption and SSL options. Through the Nirvanix CloudNAS, organizations have access to unlimited storage via the Nirvanix Storage Delivery Network with the ability to turn any server on their network into a gateway to the cloud accessible by existing applications and processes.

More information about Tech Awards Circle, including the full list of winners, is available online at http://www.techawardscircle.com or by email at info@techawardscircle.com.

About Tech Awards Circle

Tech Awards Circle was established this year to truly honor the 'best of the best' in technology. Tech Awards Circle is not affiliated with an analyst firm or a media company, both of which are directly supported by tech vendors through consulting relationships or advertising sales, so it is uniquely unbiased and immune to conflicts of interest. Entries are judged by an independent circle of journalists, including product reviewers, each with at least a decade of experience covering technology from consumer electronics to enterprise-class computing. To prevent these judges from being unduly influenced by vendors, they have agreed to remain anonymous. For more information or to be added to the mailing list please visit www.techawardscircle.com.

About Nirvanix

Nirvanix (www.nirvanix.com) is the market leader in enterprise cloud storage and offers a fully managed cloud storage service designed from the ground up for the enterprise. Headquartered in San Diego, California, Nirvanix is privately held and has raised more than $23 million in funding from world-class investors including Intel Capital, Valhalla Partners, Mission Ventures, Windward Ventures, and the European Founders Fund. Nirvanix customers range from Internet startups to Fortune 10 organizations and include Arizona State University, Nero and The Planet, among others.

For more information about the company and its services, visit www.nirvanix.com.

Nirvanix® and CloudNAS® are registered trademarks of Nirvanix Inc. Storage Delivery Network, SDN and Store. Simplify. Save. are trademarks of Nirvanix Inc. All others are trademarks or trade names of their respective owners.

    Nirvanix Contact:                          Contact Agency:
    Adrian J. Herrera                          Judy Smith
    Senior Director, Marketing                 JPR Communications
    619.764.5650 ext. 306                      818.884.8282
    adrian.herrera@nirvanix.com                judys@jprcom.com

SOURCE Nirvanix

WESTLAKE VILLAGE, Calif., Nov. 11 /PRNewswire/ -- Iconic footwear and sportswear brand K-Swiss is proud to announce the addition of American Sam Querrey to its men's tennis roster effective January 1, 2010. Under the multi-year deal, Querrey will represent K-Swiss footwear and apparel, as well as contributing to the collaborative design process for the brand's future performance product. The 24th-ranked athlete is currently the second-highest ranked American behind Andy Roddick.

Querrey, who grew up in Thousand Oaks, California, next to K-Swiss' hometown of Westlake Village, is currently the youngest-ranked American player in the top 50. He holds two ATP titles, most recently clinching the LA Tennis Open title in August 2009. Querrey will join American Mardy Fish on the K-Swiss roster.

"Sam is going to be a big part of our brand, nationally and internationally," said K-Swiss Sports Marketing Director, Erik Vervloet. "Not only is he a terrific kid with a huge game, but he also embodies the spirit of K-Swiss' California sports heritage. We look forward to having Sam with K-Swiss for the remainder of his career."

"I've always wanted to be with a brand that I could feel like part of the family," said Sam Querrey. "K-Swiss is truly interested in making the best products for me and involving me in the process. I'm looking forward to working with them and developing the best tennis brand in the world. Besides, I grew up a mile from their headquarters, so I feel like I'm at home with them."

About K-Swiss:

Located in Westlake Village, CA, K-Swiss is a publicly traded company founded more than forty years ago. K-Swiss introduced the first all-leather tennis shoe, the K-Swiss "Classic" in 1966. Since its inception, K-Swiss has rooted itself in California Sport with an aim to be the most inspiring and innovative sports brand in the market. Today the company offers performance and lifestyle footwear and apparel for several categories under its California Sports umbrella including Tennis Heritage, California Fit (Running, Triathlon and Fitness) and California Youth. For more information about K-Swiss, visit www.kswiss.com.

SOURCE K-Swiss

    Updated Analyses of Phase 1/2 Clinical Trial of Perifosine in Combination
    with Bortezomib (+/- Dexamethasone) to be Presented on Saturday,
    December 5, 2009

QUEBEC CITY, Nov. 11 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), its partner and licensee for perifosine (KRX-0401) in the North American market, will present data from a Phase 1/2 clinical trial of perifosine in combination with bortezomib (+/- dexamethasone), during a poster presentation session at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009. The clinical data to be presented demonstrates the potential safety and efficacy of perifosine in the treatment of patients with relapsed/refractory multiple myeloma.

    Details on the abstract selected for poster presentation are as follows:

    Abstract #:        1869
    Title:             Perifosine in Combination with Bortezomib and
                       Dexamethasone Extends Progression-Free Survival and
                       Overall Survival in Relapsed/Refractory Multiple
                       Myeloma Patients Previously Treated with Bortezomib:
                       Updated Phase 1/2 Trial Results
    Lead Author:       Paul Richardson, MD
    Session Name:      Myeloma - Therapy, excluding Transplantation Poster I
    Date:              Saturday, December 5, 2009
    Presentation Time: 5:30 PM - 7:30 PM
    Location:          Ernest N. Morial Convention Center, Hall E
    Poster Board no.:  I-891

This abstract became available for viewing yesterday on the ASH website (www.hematology.org). At the time of the abstract submission in mid-August 2009, there were 84 patients enrolled in the study, of which 73 were evaluable for efficacy and are reported on within the abstract. Updated efficacy (response rate, time-to-progression and survival) and safety analyses, as of mid-November 2009, will be presented at the conference.

About Perifosine

Perifosine is a novel oral anticancer agent that modulates several key signal transduction pathways, including Akt, MAPK, and JNK that have been shown to be critical for the survival of cancer cells. Perifosine has demonstrated both safety and clinical efficacy in several tumor types, both as a single agent and in combination with novel therapies. Perifosine is currently in Phase 2 clinical development for multiple tumor types, with a Phase 3 in multiple myeloma, under Special Protocol Assessment (SPA), pending commencement by year-end. Perifosine has also received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments except if we are required by a governmental authority or applicable law.

SOURCE AETERNA ZENTARIS INC.

BOSTON, Nov. 11 /PRNewswire/ -- Seanodes, creator of Exanodes® and inventor of the Shared Internal Storage (SIS) concept has taken the top award in the Midrange Software category. Winners were selected by an independent circle of publication reviewers/journalists from nominations based on a broad range of achievements - from product and technology innovations to talented executive leadership and engineering innovators.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090130/SEANODESLOGO)

Tech Awards Circle celebrates the products, services, vendors and individuals making a difference in the industry today. The winners represent a broad range of achievements, from hardware to software to services in consumer/SOHO, SMB, midrange, and enterprise markets. Gold, silver and bronze awards were given out in each category.

"Despite overwhelmingly strong competition, Seanodes exhibited true industry excellence to be recognized among the top of the Tech Awards Circle," said Kevin Anderson, awards program coordinator. "Our judges were pleased at the level of submissions from all the vendors entering this year's competition, so to be named a winner of this prestigious award is a testament to the quality and innovation unrivaled in the high tech community. We wish them continued success and look forward to them defending their title during the next awards period."

"We admire all the winners in this category because they each represent easier ways for midrange users to manage IT, contain costs, and gain functionality," said Frank Gana, Seanodes business development director. "We are honored to take home the gold medal in this unique competition, and be among the products and people recognized by the judges in this inaugural year."

Exanodes is ideal for branch office, remote office and midrange environments that are transitioning to network storage and need to maximize capacity, reliability and performance at a lower cost than traditional network storage. Exanodes VM Edition runs as a Storage Virtual Appliance, leveraging and unlocking ESX Servers storage resources and turning them into a powerful and affordable Virtual SAN in minutes. Enabling all the benefits of VMware's advanced features without the need to invest in complex and expensive traditional networked storage.

More information about Tech Awards Circle, including the full list of winners, is available online at http://www.techawardscircle.com or by email at info@techawardscircle.com.

About Tech Awards Circle

Tech Awards Circle was established this year to truly honor the 'best of the best' in technology. Tech Awards Circle is not affiliated with an analyst firm or a media company, both of which are directly supported by tech vendors through consulting relationships or advertising sales, so it is uniquely unbiased and immune to conflicts of interest. Entries are judged by an independent circle of journalists, including product reviewers, each with at least a decade of experience covering technology from consumer electronics to enterprise-class computing. To prevent these judges from being unduly influenced by vendors, they have agreed to remain anonymous. For more information or to be added to the mailing list please visit www.techawardscircle.com.

About Seanodes

The inventors of Shared Internal Storage (SIS), Seanodes is changing the face of network storage technology. Seanodes' SIS platform Exanodes runs as a Storage Virtual Appliance and radically alters the economics and possibilities in data storage and server virtualization. Seanodes, a Gartner 'Cool Vendor,' has earned multiple awards from industry analysts and media for its outstanding technology that virtualizes storage assets to convert unused internal disks and Direct Attached Storage (DAS) into a shared storage array. Founded in 2002, Seanodes is headed by storage industry veterans and backed by a number of private equity firms. More information can be found at www.seanodes.com or by calling 866-580-5515.

    CONTACT AGENCY:             CONTACT CLIENT:
    Dan Miller                  Frank Gana
    JPR Communications          Business Development Director
    818-884-8282                +33 141 22 1380
    dan@jprcom.com              gana@seanodes.com

SOURCE Seanodes

ATLANTA, Nov. 11 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that Steven G. Anderson, president and chief executive officer of CryoLife, Inc., is scheduled to present in the upcoming Lazard Capital Markets Sixth Annual Healthcare Conference on Wednesday, November 18, 2009 at 1:15 pm ET in New York City. CryoLife's live presentation may be accessed through its Web site, www.cryolife.com, on the Investor Relations page. An archived copy of the presentation will be available for 90 days on the same Web site.

CryoLife is also scheduled to present at the Sidoti & Company Emerging Growth Institutional Investor Forum on November 20, 2009. D. Ashley Lee, executive vice president, chief operating officer and chief financial officer will present at 9:40 am ET in New York City.

About CryoLife

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the U.S. and Canada. The Company's CryoValve® SG pulmonary heart valve, processed using CryoLife's proprietary SynerGraft® technology, has FDA 510(k) clearance for the replacement of diseased, damaged, malformed, or malfunctioning native or prosthetic pulmonary valves. The Company's CryoPatch® SG pulmonary cardiac patch has FDA 510(k) clearance for the repair or reconstruction of the right ventricular outflow tract (RVOT), which is a surgery commonly performed in children with congenital heart defects, such as Tetralogy of Fallot, Truncus Arteriosus, and Pulmonary Atresia. CryoPatch SG is distributed in three anatomic configurations: pulmonary hemi-artery, pulmonary trunk, and pulmonary branch. The Company's BioGlue® Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company's BioFoam® Surgical Matrix is CE marked in the European Community for use as an adjunct in the sealing of abdominal parenchymal tissues (liver and spleen) when cessation of bleeding by ligature or other conventional methods is ineffective or impractical. BIOGLUE Aesthetic(TM) Medical Adhesive is CE marked in the European Community for periosteal fixation following endoscopic browplasty (brow lift) in reconstructive plastic surgery and is distributed by a third party for this indication. CryoLife distributes HemoStase(TM), a hemostatic agent, in much of the U.S. for use in cardiac and vascular surgery and in the European Community and Canada for cardiac, vascular, and general surgery, subject to certain exclusions.

For additional information about the Company, visit CryoLife's Web Site: http://www.cryolife.com.

    Media Contacts:

    D. Ashley Lee
    Executive Vice President, Chief Financial Officer and
    Chief Operating Officer
    Phone: 770-419-3355

SOURCE CryoLife, Inc.